These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 20620880)

  • 1. Foreword. Importance of physical health in patients with schizophrenia.
    Höschl C
    Eur Psychiatry; 2010 Jun; 25 Suppl 2():S1-2. PubMed ID: 20620880
    [No Abstract]   [Full Text] [Related]  

  • 2. The need for routine physical health care in schizophrenia.
    Montejo AL
    Eur Psychiatry; 2010 Jun; 25 Suppl 2():S3-5. PubMed ID: 20620884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical health in schizophrenia: a challenge for antipsychotic therapy.
    Heald A
    Eur Psychiatry; 2010 Jun; 25 Suppl 2():S6-11. PubMed ID: 20620888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy and tolerance of antipsychotic agents: what are the current issues?].
    Canceil O
    Encephale; 2006 Oct; 32(5 Pt 4):S927-8. PubMed ID: 17119510
    [No Abstract]   [Full Text] [Related]  

  • 5. Obesity, diabetes, and the metabolic syndrome: new challenges in antipsychotic drug therapy.
    Caballero E
    CNS Spectr; 2003 Nov; 8(11 Suppl 2):19-22. PubMed ID: 14978454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes prevalence estimates in schizophrenia and risk factor assessment.
    Argo T; Carnahan R; Barnett M; Holman TL; Perry PJ
    Ann Clin Psychiatry; 2011 May; 23(2):117-24. PubMed ID: 21547272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical health management in psychiatric settings.
    De Hert M; van Winkel R; Silic A; Van Eyck D; Peuskens J
    Eur Psychiatry; 2010 Jun; 25 Suppl 2():S22-8. PubMed ID: 20620882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and awareness of cardiovascular risk factors in patients with schizophrenia: a cross-sectional study in a low cardiovascular disease risk geographical area.
    Bernardo M; Cañas F; Banegas JR; Casademont J; Riesgo Y; Varela C;
    Eur Psychiatry; 2009 Oct; 24(7):431-41. PubMed ID: 19783126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schizophrenia, antipsychotics and metabolic disease.
    Reynolds GP
    J Psychopharmacol; 2007 Jun; 21(4):355-6. PubMed ID: 17656424
    [No Abstract]   [Full Text] [Related]  

  • 10. Schizophrenia, antipsychotics, and the metabolic syndrome: is there a silver lining?
    Remington G
    Am J Psychiatry; 2006 Jul; 163(7):1132-4. PubMed ID: 16816213
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic syndrome in patients with psychotic disorders: diagnostic issues, comorbidity and side effects of antipsychotics.
    Kozumplik O; Uzun S; Jakovljević M
    Psychiatr Danub; 2010 Mar; 22(1):69-74. PubMed ID: 20305594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors in antipsychotic drug selection: tolerability considerations.
    Nasrallah HA
    CNS Spectr; 2003 Nov; 8(11 Suppl 2):23-5. PubMed ID: 14978455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome in patients with schizophrenia: CATIE results.
    Narasimhan M; Masand P
    Curr Psychiatry Rep; 2006 Jun; 8(3):213-4. PubMed ID: 19817071
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of a health screening clinic.
    Millar HL
    Eur Psychiatry; 2010 Jun; 25 Suppl 2():S29-33. PubMed ID: 20620883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of medical comorbidity on medication management of schizophrenia.
    Haupt DW
    CNS Spectr; 2007 Dec; 12(12 Suppl 21):15-7. PubMed ID: 18389928
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic issues in patients with severe mental illness.
    Citrome L; Blonde L; Damatarca C
    South Med J; 2005 Jul; 98(7):714-20. PubMed ID: 16108240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychofarmacology in the prevention of somatic comorbid diseases in mentally ill patients.
    Jukić V; Petrović Z; Brecić P; Krizaj A; Savić A; Baceković A; Bilić P; Susac J; Mandić A; Prazen I
    Psychiatr Danub; 2009 Sep; 21(3):350-5. PubMed ID: 19794355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of cardiovascular disease and sudden death in schizophrenia.
    Davidson M
    J Clin Psychiatry; 2002; 63 Suppl 9():5-11. PubMed ID: 12088174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Retrospective Chart Review of Screening on the Prevalence of Metabolic Syndrome (MetS) in an Irish Community Mental Health Service.
    Cocoman AM; Gallagher D
    Issues Ment Health Nurs; 2019 Oct; 40(10):895-901. PubMed ID: 31295053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Exercising caution in choice of psychotropic drugs. Avoid drug-induced weight gain].
    MMW Fortschr Med; 2002 May; Suppl 2():89. PubMed ID: 12070872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.